Myelopathy following intrathecal chemotherapy in a patient with extensive burkitt's lymphoma and altered immune status
dc.contributor.author | Bates, Susan Weil | en_US |
dc.contributor.author | McKeever, Paul E. | en_US |
dc.contributor.author | Masur, Henry | en_US |
dc.contributor.author | Levens, David | en_US |
dc.contributor.author | Macher, Abe | en_US |
dc.contributor.author | Armstrong, Gary | en_US |
dc.contributor.author | Magrath, Ian T. | en_US |
dc.date.accessioned | 2006-04-07T19:07:33Z | |
dc.date.available | 2006-04-07T19:07:33Z | |
dc.date.issued | 1985-04 | en_US |
dc.identifier.citation | Bates, Susan, McKeever, Paul, Masur, Henry, Levens, David, Macher, Abe, Armstrong, Gary, Magrath, Ian T. (1985/04)."Myelopathy following intrathecal chemotherapy in a patient with extensive burkitt's lymphoma and altered immune status." The American Journal of Medicine 78(4): 697-702. <http://hdl.handle.net/2027.42/25727> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6TDC-4CDRGJT-2X/2/924d29087e1cbc48d28405037aa308fb | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/25727 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2580436&dopt=citation | en_US |
dc.description.abstract | A 30-year-old homosexual man presented with widespread Burkitt's lymphoma. On the basis of immunologic and viral studies, he was suspected of having the acquired Immune deficiency syndrome. Following chemotherapy that included Intrathecal cytosine arabinoside and methotrexate, brain stem edema, paraplegia, and an elevated cerebrospinal fluid level of myelin basic protein developed. Autopsy revealed vacuolar demyelination of spinal cord, brain stem, and cerebellum. The pathologic findings were similar to those reported to occur In myelopathy associated with intrathecal chemotherapy, but far more extensive. The contribution of the suspected acquired immune deficiency syndrome is unknown. | en_US |
dc.format.extent | 3551634 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Myelopathy following intrathecal chemotherapy in a patient with extensive burkitt's lymphoma and altered immune status | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Family Medicine and Primary Care | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, the Critical Care Medicine Department, Clinical Center, Bethesda, Maryland, USA; Laboratory of Pathology, Division of Cancer Biology and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA | en_US |
dc.contributor.affiliationother | Food and Drug Administration, Bureau of Biologics, Division of Virology, Bethesda, Maryland, USA | en_US |
dc.contributor.affiliationother | Food and Drug Administration, Bureau of Biologics, Division of Virology, Bethesda, Maryland, USA | en_US |
dc.contributor.affiliationother | Food and Drug Administration, Bureau of Biologics, Division of Virology, Bethesda, Maryland, USA | en_US |
dc.contributor.affiliationother | Food and Drug Administration, Bureau of Biologics, Division of Virology, Bethesda, Maryland, USA | en_US |
dc.identifier.pmid | 2580436 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/25727/1/0000284.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-9343(85)90417-6 | en_US |
dc.identifier.source | The American Journal of Medicine | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.